Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Bio Essence (BIOE) Notes Payables (2020 - 2025)

Bio Essence (BIOE) has 6 years of Notes Payables data on record, last reported at $6966.0 in Q2 2025.

  • For Q2 2025, Notes Payables changed N/A year-over-year to $6966.0; the TTM value through Jun 2025 reached $6966.0, changed N/A, while the annual FY2023 figure was $9436.0, 82.41% down from the prior year.
  • Notes Payables reached $6966.0 in Q2 2025 per BIOE's latest filing, up from $2414.0 in the prior quarter.
  • Across five years, Notes Payables topped out at $70860.0 in Q1 2023 and bottomed at $2414.0 in Q1 2025.
  • Average Notes Payables over 5 years is $28153.4, with a median of $27744.0 recorded in 2022.
  • Peak YoY movement for Notes Payables: soared 181.9% in 2022, then plummeted 96.43% in 2024.
  • A 5-year view of Notes Payables shows it stood at $19032.0 in 2021, then skyrocketed by 181.9% to $53651.0 in 2022, then plummeted by 82.41% to $9436.0 in 2023, then plummeted by 73.17% to $2532.0 in 2024, then skyrocketed by 175.12% to $6966.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Notes Payables were $6966.0 in Q2 2025, $2414.0 in Q1 2025, and $2532.0 in Q1 2024.